Troponin I and T and Adverse Outcomes in Patients With and Without Diabetes Mellitus After Coronary Intervention

W

Wilhelminenspital Vienna

Status

Completed

Conditions

Coronary Artery Disease
Diabetes Mellitus

Treatments

Other: Percutaneous coronary intervention

Study type

Observational

Funder types

Other

Identifiers

NCT03627455
TROPDM2GENDER

Details and patient eligibility

About

Elevated levels of troponin are associated with future MACE. Data on the prognostic value of high sensitive troponin T (hs-TnT) as compared to high sensitive troponin I (hs-TnI) in diabetic and non-diabetic patients are sparse. We aimed to assess the risk for MACE according to gender and diabetes status and to compare the prognostic value of hs-TnT and hs-TnI with regards to clinical outcomes in diabetic and non-diabetic patients undergoing percutaneous coronary intervention (PCI).

Enrollment

818 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Percutaneous coronary intervention

Exclusion criteria

unsuccessful percutaneous coronary intervention

Trial design

818 participants in 4 patient groups

Male, with DM
Treatment:
Other: Percutaneous coronary intervention
Male, without DM
Treatment:
Other: Percutaneous coronary intervention
Female, with DM
Treatment:
Other: Percutaneous coronary intervention
Female, without DM
Treatment:
Other: Percutaneous coronary intervention

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems